Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.61 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29405923 | 0.82 | ALDH1A1 (0.63) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL30001820 | 0.81 | ALDH1A1 (0.68) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL27144 | 0.81 | ALDH1A1 (0.68) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL78553 | 0.81 | ALDH1A1 (0.68) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL37382 | 0.81 | ALDH1A1 (0.68) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL1834864 | 0.80 | ALDH1A1 (0.70) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL21424841 | 0.79 | ALDH1A1 (0.63) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL18499924 | 0.79 | ALDH1A1 (0.55) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| Ammonia Solution, Strong SCHEMBL9998884 | 0.79 | ALDH1A1 (0.65) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| Hydrogen Sulfide SCHEMBL2021838 | 0.79 | ALDH1A1 (0.65) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240368324-A1 | PLANT-INSPIRED ZWITTERIONIC MONOMERS, POLYMERS, AND USES THEREOF | TRUSTEES OF TUFTS COLLEGE | 2024-11-07 | — | — | US | disclosed |
| US-20230321042-A1 | COMBINATION THERAPY | PFIZER INC. (US) | 2023-10-12 | — | — | US | disclosed |
| WO-2023173026-A1 | ANTIBODY-DRUG CONJUGATES AND USES THEREOF | SORRENTO THERAPEUTICS, INC. (US) | 2023-09-14 | — | — | WO | disclosed |
| US-20230203215-A1 | METHOD FOR PRODUCING IODINE-CONTAINING COMPOUND, AND IODINE-CONTAINING COMPOUND | AGC Inc. (JP) | 2023-06-29 | — | — | US | disclosed |
| EP-4194039-A1 | A METHOD TO ATTAIN A TARGETED END TIDAL PARTIAL PRESSURE OF A GAS | Thornhill Scientific Inc. (CA) | 2023-06-14 | — | — | EP | disclosed |
| WO-2023071012-A1 | FULLY CLOSED-LOOP ARTIFICIAL PANCREAS DRUG INFUSION CONTROL SYSTEM | MEDTRUM TECHNOLOGIES INC. (CN) | 2023-05-04 | — | — | WO | disclosed |
| WO-2023070714-A1 | CLOSED-LOOP ARTIFICIAL PANCREAS DRUG INFUSION CONTROL SYSTEM | MEDTRUM TECHNOLOGIES INC. (CN) | 2023-05-04 | — | — | WO | disclosed |
| WO-2023070251-A1 | CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM | MEDTRUM TECHNOLOGIES INC. (CN) | 2023-05-04 | — | — | WO | disclosed |
| WO-2023070253-A1 | CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM | MEDTRUM TECHNOLOGIES INC. (CN) | 2023-05-04 | — | — | WO | disclosed |
| WO-2023070713-A1 | CLOSED-LOOP ARTIFICIAL PANCREAS DRUG INFUSION CONTROL SYSTEM | MEDTRUM TECHNOLOGIES INC. (CN) | 2023-05-04 | — | — | WO | disclosed |
| US-20110152243-A1 | NOVEL THIENOPYRROLE COMPOUNDS | ABBOTT LABORATORIES (US) | 2011-06-23 | — | — | US | disclosed |
| US-20100137364-A1 | 6-Aminoisoquinoline Compounds | AERIE PHARMACEUTICALS, INC. (US) | 2010-06-03 | — | — | US | disclosed |
| US-20100029947-A1 | Pyridyltetrahydropyridines and Pyridylpiperidines, and Method of Manufacturing Them | FUJIFILM FINECHEMICALS CO., LTD | 2010-02-04 | — | — | US | disclosed |
| US-20090318423-A1 | Ion Channel Modulators & Uses Thereof | LECTUS THERAPEUTICS LIMITED (GB) | 2009-12-24 | — | — | US | disclosed |
| US-7632950-B2 | Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them | FUJIFILM FINECHEMICALS CO., LTD (JP) | 2009-12-15 | — | — | US | disclosed |
| US-20090298823-A1 | Inhibitors of protein kinases | PORTOLA PHARMACEUTICALS, INC. (US) | 2009-12-03 | — | — | US | disclosed |
| EP-2109000-A1 | Polymer having polymerizable group, polymerizable composition, planographic printing plate precursor, and planographic printing method using the same | FUJIFILM Corporation (JP) | 2009-10-14 | — | — | EP | disclosed |
| US-20090105091-A1 | Modified Amino Acids | TECHNISCHE UNIVERSITAT WIEN (AT) | 2009-04-23 | — | — | US | disclosed |
| US-20070093528-A1 | Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them | FUJIFILM FINECHEMICALS CO., LTD (JP) | 2007-04-26 | — | — | US | disclosed |
| EP-1657240-A1 | PYRIDYLTETRAHYDROPYRIDINES, PYRIDYLPIPERIDINES, AND PROCESS FOR THE PRODUCTION OF BOTH | FUJIFILM FINECHEMICALS CO., LTD. (JP) | 2006-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105091-A1 | Modified Amino Acids | SLC1A2, NR1H4, OXGR1 | ALDH1A1 1588/4885TDP1 4722/4885MAPK1 2380/4885 |
| US-20100137364-A1 | 6-Aminoisoquinoline Compounds | COQ8A, PGC, AGK | ALDH1A1 2478/4885TDP1 1046/4885MAPK1 385/4885 |
| US-20100029947-A1 | Pyridyltetrahydropyridines and Pyridylpiperidines, and Method of Manufacturing Them | QDPR, HRH4, HRH2 | ALDH1A1 876/4885TDP1 3054/4885MAPK1 2781/4885 |
| US-20070093528-A1 | Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them | QDPR, HRH4, HRH2 | ALDH1A1 950/4885TDP1 3157/4885MAPK1 2582/4885 |
| US-20110152243-A1 | NOVEL THIENOPYRROLE COMPOUNDS | TPMT, TSLP, THPO | ALDH1A1 297/4885TDP1 2210/4885MAPK1 1068/4885 |
| US-20090318423-A1 | Ion Channel Modulators & Uses Thereof | KCNH3, KCNN3, KCNH2 | ALDH1A1 1965/4885TDP1 4039/4885MAPK1 2560/4885 |
| US-20230321042-A1 | COMBINATION THERAPY | CDK4, CDK6, CDK2 | ALDH1A1 2046/4885TDP1 2377/4885MAPK1 455/4885 |
| US-20090298823-A1 | Inhibitors of protein kinases | SYK, BTK, JAK2 | ALDH1A1 3049/4885TDP1 787/4885MAPK1 209/4885 |
| US-20230203215-A1 | METHOD FOR PRODUCING IODINE-CONTAINING COMPOUND, AND IODINE-CONTAINING COMPOUND | SSTR2, TPO, BRI3BP | ALDH1A1 1643/4885TDP1 4698/4885MAPK1 1060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.